Q-omics provides the consensus-scored RNA5SP498 profile across patient tissues and cancer cell-line models. RNA5SP498 expression is associated with patient survival in 15 of 34 cancer types, with the highest sampling consensus in KIRC. Among the 18 cancer types available for tumor–normal comparison, RNA5SP498 is differentially expressed in 10, with the highest sampling consensus in STAD. Additionally, RNA5SP498 RNA expression shows 11,073 significant gene co-expression associations, with the highest sampling consensus in TGCT. Together, these results highlight KIRC, STAD, and TGCT as cancer lineages where RNA5SP498 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for RNA5SP498 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes RNA5SP498 survival associations across molecular data types. RNA5SP498 RNA expression shows survival associations in the most cancer types (15). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible RNA5SP498 RNA expression–survival associations across cancer types. High RNA5SP498 expression shows unfavorable associations in KIRC, OV and ACC, but favorable associations in DLBC, CESC and BRCA. The KIRC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify KIRC as the clearest survival context for RNA5SP498 RNA expression.
This table summarizes RNA5SP498 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 10. The strongest signals are observed in STAD for RNA.
This table ranks reproducible tumor–normal expression differences for RNA5SP498. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. RNA5SP498 shows lower tumor expression in BRCA and higher tumor expression in STAD, KIRP, COAD, ESCA and KIRC. The STAD box plot shows higher RNA5SP498 RNA expression in tumor versus normal tissue (log2 FC = +1.548, t-test p < 0.001).
This table shows molecular features associated with RNA5SP498 in patient tissues and cancer cell lines. In patient samples, RNA5SP498 shows the broadest associations at the RNA and protein expression levels, with TGCT recurring as the lineage with the largest associated feature set.
